Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
Counterpart Health (Nasdaq: CLOV) announced two senior hires to accelerate enterprise partnerships and regional adoption of its AI‑powered platform Counterpart Assistant (CA). Blaine Lindsey joins as Vice President of Enterprise Growth and Partnerships to pursue national, risk‑bearing partnerships and convert inbound demand into strategic deployments. Shannon Jacobs becomes President of Market Operations for the Gulf Region to scale operations, launch new markets, and support clinicians in underserved, high‑need areas. The appointments target faster clinician adoption of AI insights within existing workflows to identify high‑risk patients and support value‑based care at scale.
Counterpart Health (Nasdaq: CLOV) ha annunciato due assunzioni senior per accelerare le partnership aziendali e l'adozione regionale della sua piattaforma alimentata dall'IA Counterpart Assistant (CA). Blaine Lindsey entra come Vicepresidente per la crescita e le partnership aziendali per perseguire partnership a livello nazionale con assunzione di rischi e convertire la domanda in ingresso in implementazioni strategiche. Shannon Jacobs diventa President of Market Operations per la Gulf Region per aumentare le operazioni, lanciare nuovi mercati e supportare i clinici in aree svantaggiate e ad alto bisogno. Le nomine mirano a un'adozione più rapida da parte dei clinici delle intuizioni IA all'interno dei flussi di lavoro esistenti per identificare pazienti ad alto rischio e sostenere la cura basata sul valore su scala.
Counterpart Health (Nasdaq: CLOV) anunció dos contrataciones de alto nivel para acelerar las asociaciones empresariales y la adopción regional de su plataforma impulsada por IA Counterpart Assistant (CA). Blaine Lindsey se une como Vicepresidente de Crecimiento Empresarial y Alianzas para buscar asociaciones nacionales con gestión de riesgos y convertir la demanda entrante en implementaciones estratégicas. Shannon Jacobs se convierte en Presidenta de Operaciones de Mercado para la Región del Golfo para escalar operaciones, lanzar nuevos mercados y apoyar a los clínicos en áreas desatendidas y de alta necesidad. Los nombramientos tienen como objetivo una adopción más rápida de las perspectivas de IA por parte de los clínicos dentro de los flujos de trabajo existentes para identificar pacientes de alto riesgo y apoyar la atención basada en el valor a gran escala.
Counterpart Health (나스닥: CLOV)은 AI 기반 플랫폼 Counterpart Assistant (CA)의 기업 파트너십 및 지역 채택을 가속화하기 위해 두 명의 수석 직원을 발표했습니다. Blaine Lindsey는 엔터프라이즈 성장 및 파트너십 부사장으로 합류하여 전국적 위험 부담 파트너십을 추진하고 인입 수요를 전략적 배포로 전환합니다. Shannon Jacobs는 걸프 지역의 시장 운영 사장으로서 운영 규모화를 추진하고, 새 시장을 개척하고, 서비스가 부족하고 수요가 높은 지역의 임상의들을 지원합니다. 이 임명은 기존 워크플로우 내에서 임상의의 AI 인사이트 채택을 더 빠르게 달성하여 고위험 환자를 식별하고 대규모 가치 기반 치료를 지원하는 것을 목표로 합니다.
Counterpart Health (NASDAQ : CLOV) a annoncé deux recrutements de haut niveau pour accélérer les partenariats d'entreprise et l'adoption régionale de sa plateforme alimentée par l'IA Counterpart Assistant (CA). Blaine Lindsey rejoint en tant que Vice-président de la croissance d'entreprise et des partenariats afin de poursuivre des partenariats nationaux avec gestion du risque et de convertir la demande entrante en déploiements stratégiques. Shannon Jacobs devient Présidente des Opérations de Marché pour la région du Golfe afin de scaler les opérations, lancer de nouveaux marchés et soutenir les cliniciens dans des zones mal desservies et à forte demande. Ces nominations visent une adoption plus rapide par les cliniciens des insights IA au sein des flux de travail existants pour identifier les patients à haut risque et soutenir les soins fondés sur la valeur à grande échelle.
Counterpart Health (NASDAQ: CLOV) gab zwei Senior-Hires bekannt, um Partnerschaften auf Unternehmensebene zu beschleunigen und die regionale Einführung seiner KI-gesteuerten Plattform Counterpart Assistant (CA) zu beschleunigen. Blaine Lindsey tritt als Vice President of Enterprise Growth and Partnerships bei, um nationale Partnerschaften mit Risikoübernahme zu verfolgen und eingehende Nachfrage in strategische Implementierungen zu verwandeln. Shannon Jacobs wird Präsidentin der Marktoperationen für die Golfregion, um die Operationen zu skalieren, neue Märkte zu eröffnen und Kliniker in unterversorgten, stark nachgefragten Gebieten zu unterstützen. Die Ernennungen zielen darauf ab, die Akzeptanz von KI-gesteuerten Einsichten der Kliniker in bestehenden Arbeitsabläufen schneller zu erhöhen und so Hochrisikopatienten zu identifizieren und eine wertbasierte Versorgung in großem Maßstab zu unterstützen.
Counterpart Health (نازداك: CLOV) أعلنت عن تعيينين رفيعي المستوى لتسريع الشراكات المؤسسية واعتماد منصتها المدعومة بالذكاء الاصطناعي Counterpart Assistant (CA). ينضم Blaine Lindsey كنائب رئيس للنمو المؤسسي والشراكات لملاحقة الشراكات الوطنية التي تتحمل المخاطر وتحويل الطلب الوارد إلى نشرات استراتيجية. تصبح Shannon Jacobs رئيسة عمليات السوق لمنطقة الخليج لتوسيع العمليات، وفتح أسواق جديدة، ودعم الأطباء في المناطق المحرومة والمرتفعة الاحتياج. تستهدف التعيينات تسريع اعتماد رؤى الذكاء الاصطناعي من قبل الأطباء ضمن سير العمل الحالي لتحديد المرضى عاليي الخطر ودعم الرعاية القائمة على القيمة على نطاق واسع.
Counterpart Health (纳斯达克: CLOV) 宣布任命两位高级人员，以加速企业级伙伴关系与其 AI 驱动平台 Counterpart Assistant (CA) 的区域采用。Blaine Lindsey 将出任企业增长与伙伴关系副总裁，致力于推动全国范围内的风险承担型伙伴关系，并将来电需求转化为战术部署。Shannon Jacobs 将成为海湾地区市场运营总裁，以扩大运营规模、开拓新市场，并在服务不足、需求高的地区支持临床医生。这些任命旨在在现有工作流程中更快地采用 AI 洞察，识别高风险患者，并在大规模范围内支持基于价值的护理。
- None.
- None.
New VP Blaine Lindsey to Drive National Enterprise Growth; Gulf Region President Shannon Jacobs to Scale Operations in High-Need Markets
SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI‑powered physician‑enablement platform, today announced that Blaine Lindsey, Vice President of Enterprise Growth and Partnerships and Shannon Jacobs, President of Market Operations for the Gulf Region have joined Counterpart Health. These two strategic leadership appointments are integral to nurturing new partnerships and ensuring operational support for successful adoption of Counterpart Assistant (CA).
These appointments come during a time when many physicians lack the technology infrastructure and operational support to successfully implement value-based care, especially in underserved areas where clinicians may have limited resources. CA addresses this gap by surfacing AI-powered insights into existing clinician workflows, enabling them to identify high-risk patients, manage chronic conditions earlier, and support value-based care at scale.
"Counterpart Assistant was built to serve the full spectrum of physician practices," said Conrad Wai, CEO of Counterpart Health. "Whether we're partnering with large health systems, national plans, regional payviders, or independent practices in rural communities, we’ve identified that the need is the same: actionable intelligence that improves care without overwhelming providers. Blaine and Shannon bring the expertise to scale our impact while ensuring we deliver meaningful results.”
Driving National Enterprise Partnerships
As Vice President of Enterprise Growth and Partnerships, Blaine Lindsey will be instrumental in bringing Counterpart Assistant to more risk-bearing organizations, and ultimately, more clinicians and patients. Lindsey is a highly accomplished healthcare leader and nationally recognized value-based care expert whose experience includes leading national provider and enterprise partnerships at Aledade and Honest Health as well as driving expansion as Chief Growth Officer at AnsibleHealth. Lindsey brings a proven track record of building innovative, high performance partnerships that deliver both clinical and financial value.
“Counterpart’s technology has proven itself in real-world deployments and consistently outperforms in actual practice settings,” said Blaine Lindsey. “The healthcare ecosystem is taking notice of Counterpart Assistant with new partners requesting access, and inbound demand is building quickly. My priority is to convert that momentum into strategic partnerships that deliver reliable, measurable results for clinicians while scaling adoption within existing workflows.”
Scaling Operations in the Gulf Region's Diverse Markets
Shannon Jacobs joins as President of Market Operations for the Gulf Region, where he'll lead the expansion and performance optimization of Counterpart’s growing physician network. Jacobs most recently served as President of the Gulf Region at Main Street Health, the nation's largest value-based care provider in rural communities. He brings deep operational expertise in launching new markets, building high-performing teams, and supporting excellent clinical care delivery across diverse practice environments.
"I've worked closely with primary care providers for years and have tremendous respect for how they navigate a myriad of challenges, especially in areas where resources are tight and patient complexity is high,” said Shannon Jacobs. “What excites me about Counterpart Assistant is the opportunity to support these hard-working providers with valuable clinical data and AI-enabled technology that fits into their existing workflows and allows them to deliver high quality care to their patients.”
About Counterpart Health
Counterpart Health, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI-powered physician enablement platform transforming care delivery. Born out of Clover Health as Clover Assistant, Counterpart Health’s flagship software platform, Counterpart Assistant, provides clinically intuitive insights that help clinicians better manage chronic conditions and deliver high-quality care. Counterpart Health extends this powerful data-driven technology platform beyond Clover Health’s Medicare Advantage plan, bringing its benefits to a wider audience to improve patient outcomes and reduce healthcare costs nationwide. Several published studies demonstrate the technology’s impact on Diabetes, Chronic Kidney Disease, Congestive Heart Failure, and Chronic Obstructive Pulmonary Disease management, and Clinical Quality.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
FAQ
What will Blaine Lindsey do as VP of Enterprise Growth at Counterpart Health (CLOV)?
How will Shannon Jacobs' role impact Counterpart adoption in the Gulf Region (CLOV)?
Does the announcement provide financial guidance or revenue impact for Clover Health (CLOV)?
What clinical problems does Counterpart Assistant aim to address for physicians?
Will these leadership hires expand Counterpart Assistant to new partners and regions in 2025?
